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Pathogenic variants in ZMYND11, which acts as a transcriptional repressor, have been associated with
intellectual disability, behavioural abnormalities and seizures. Only 11 affected individuals have been
reported to-date, and the phenotype associated with pathogenic variants in this gene have not been fully
defined.
 
Here, we present 16 additional patients with predicted pathogenic heterozygous variants in ZMYND11,
including four individuals from the same family, to further delineate and expand the genotypic and
phenotypic spectrum of ZMYND11-related syndromic intellectual disability. The associated phenotype
includes developmental delay, particularly affecting speech, mild-moderate intellectual disability,
significant behavioural abnormalities, seizures, and hypotonia. There are subtle shared dysmorphic
features, including prominent eyelashes and eyebrows, depressed nasal bridge with bulbous nasal tip,
anteverted nares, thin vermilion of the upper lip and wide mouth. Novel features include brachydactyly
and tooth enamel hypoplasia.
Most identified variants are likely to result in premature truncation and/or nonsense mediated decay. Two
ZMYND11 variants located in the final exon - p.(Gln586*) (likely escaping nonsense-mediated decay)
and p.(Cys574Arg) - are predicted to disrupt the MYND-type zinc finger motif and likely interfere with
binding to its interaction partners. Hence, the homogeneous phenotype likely results from a common
mechanism of loss-of-function.
 




The chromosome 10p15.3 microdeletion syndrome is characterised by developmental delay (DD) and
intellectual disability (ID), craniofacial dysmorphism, behavioural abnormalities, hypotonia, and seizures
(DeScipio et al., 2013). Haploinsufficiency of ZMYND11 (NCBI Gene ID: 10771) is believed to account
for many of the features associated with chromosome 10p15.3 microdeletion (Tumiene et al., 2017).
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ZMYND11 has been shown to act as a transcriptional repressor by inhibiting the elongation phase of
RNA Polymerase II by recognizing histone modification present in transcribed regions, specifically
H3K36 trimethylation (Wen et al., 2014).
 
In support of the critical role of ZMYND11 in the chromosome 10p15.3 microdeletion syndrome, patients
with de novo truncating variants in ZMYND11 have a similar phenotype, including ID, seizures, and
beavioural issues (Coe, Witherspoon, Rosenfeld, van Bon, et al., 2014; Popp et al., 2017). In addition,
missense variants in this gene have also been associated with ID and seizures, although there is a more
severe phenotype in patients with specific variants, which may be related to a gain-of-function
mechanism (Cobben et al., 2014; Moskowitz et al., 2016). A splice site variant has also been reported in a
child with autism spectrum disorder (Iossifov et al., 2012). In total, 11 patients with pathogenic variants
in ZMYND11 (MIM# 616083) have been reported to date (Aoi et al., 2019; Cobben et al., 2014; Coe,
Witherspoon, Rosenfeld, Van Bon, et al., 2014; Iossifov et al., 2012; Moskowitz et al., 2016; Popp et al.,
2017).
 
Here, we present 16 previously unreported individuals with pathogenic variants in ZMYND11, including
four from the same family. We further delineate and expand the genotype-phenotype correlations and
phenotypic spectrum of ZMYND11-related intellectual disability.
Methods
 
All patients were ascertained after routine referral to their local Clinical Genetics service. Patients 1, 3, 5
and 8 were gathered through international collaboration using GeneMatcher (Sobreira, Schiettecatte,
Valle, & Hamosh, 2016). Patients 2, 6, 7, 9, 11 and 12 were identified through the Wellcome Trust
Deciphering Developmental Disorders study (Wright et al., 2015). Patients 13-15 were identified as
affected relatives of patient 12. Patients 4, 10 and 16 were identified through personal communication.
Exome sequencing was performed on all probands, with a trio approach on patients  1, 3, 5, 6, 9-12, and
16; a duo approach on patients 2, 4, 7, and 8, as DNA samples were only available from one parent.
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Sanger sequencing only was used to ascertain the presence of the familial variant in patients 13-15, and
all other patients had their ZMYND11 variant confirmed using this method. All sequence variants were
described with reference to ZMYND11 transcript NM_006624.5. All variants were classified according to
the American College of Medical Genetics (ACMG) guidelines (Richards et al., 2015). Further
information is available in the supplemental data. Patient variants have been uploaded to either ClinVar






16 individuals (including 13 probands and two additional children of one affected mother) had a
predicted pathogenic variant in ZMYND11. Of these, eight were de novo, one was inherited by three sibs
from their affected mother, one was paternally-inherited, and three were of unknown inheritance. Ten
variants were predicted to result in protein truncation, two were missense, and one affected a splice site
(Table 1). None of the variants in this series were present in the gnomAD database (v2.1.1) (Karczewski
et al., 2019). Of the two missense variants, one was located in a zinc finger domain (c.1720T>C; p.
(Cys574Arg)), and the other was not in a known functional domain (c.1246G>A; p.(Glu416Lys)). Further




Phenotypic information for all patients is shown in Table 1 In-depth patient summaries are available in
the supplemental data (Supp. Patient Summaries). Prominent phenotypic features are detailed below. The
denominators refer to the number of patients for whom the specific information is available.
 
Birth weight was at or above the 98th centile in three patients (3/14; 21%). Feeding problems (e.g. excess
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vomiting after feeds, bottle feeding requiring more than one hour), were present in 6/13 patients (46%).
Most patients had normal growth parameters and head circumference.
 
Development was delayed in all patients (14/14; 100%). The median age at independent walking was 24
months (with age range of 17 months to four years). Three patients remained unable to walk at the ages
of two-and-a-half (for two individuals) and four years, respectively. Speech delay was prominent, with
14/14 (100%) affected. First words were achieved at a median age of two-and-a-half years (with age
range of two years to four years). Two patients were non-ambulatory, and  had not achieved speech at
two-and-a-half and four years age respectively (2/14; 14%). All patients had mild to moderate intellectual
disability (13/13; 100%).
 
Almost all patients had behavioural issues (14/16; 88%). These include attention deficit, hyperactivity
and impulsivity (8/16; 50%), aggressive behaviour (8/16; 50%), and autism spectrum disorder or autistic
traits (3/15; 20%). Neurological abnormalities were detected in 10/16 (63%); mostly hypotonia (5/16;
31%) and epilepsy (5/16; 31%).
 
Photographs of patients in this series are shown in Fig. 1. Dysmorphic facial features were judged to be
present in 11/16 (69%). There were a number of shared facial features, including thick eyebrows,
prominent eyelashes, depressed nasal bridge with bulbous nose, anteverted nares, thin vermilion of the
upper lip and wide mouth.
Patients 12-14 in this series inherited their ZMYND11 variant from their mother (patient 15). All
individuals in this family had special educational needs; two of the siblings are now in employment. The
ZMYND11 variant found in Patient 9 was paternally inherited. Detailed phenotypic information is not
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Here, we present 16 new individuals with predicted pathogenic variants in ZMYND11. Comparison with
all previously published patients allows further delineation of the phenotypic spectrum associated with
mutations in this gene (Table 2) (Supp. Table S1) (Aoi et al., 2019; Cobben et al., 2014; Coe,
Witherspoon, Rosenfeld, van Bon, et al., 2014; Iossifov et al., 2012; Moskowitz et al., 2016; Popp et al.,
2017).
 
All patients (including our series) had developmental delay, particularly affecting speech, and ID. The
severity of ID in this series is mild to moderate, but four patients have previously been described with
severe ID (Cobben et al., 2014; Coe, Witherspoon, Rosenfeld, van Bon, et al., 2014; Moskowitz et al.,
2016; Popp et al., 2017). Behavioural issues are also a prominent feature both in our series and in those
previously published (Coe, Witherspoon, Rosenfeld, van Bon, et al., 2014; Popp et al., 2017) , including
aggression, attention deficit/hyperactivity, and autism/autistic traits. Therefore, this series provides
further evidence that behavioural abnormalities are a significant part of the ZMYND11-associated
phenotype. These behavioural problems may pose a substantial psychosocial burden, especially if the
intellectual disability is mild. Hypotonia and epilepsy affect 48% and 39% of all patients, respectively
(including our series). This enables us to indisputably establish hypotonia and epilepsy as part of the
phenotype associated with this syndrome. 
 
Dysmorphic features, particularly thick eyebrows, prominent eyelashes and a bulbous nose, are present in
the majority of patients (Fig. 1). These are in line with the patients reported by Coe et al., (2014). These
dysmorphisms may prove useful with regard to reverse phenotyping. Feeding difficulties were present in
59% of all patients (including our series), although only three patients required supplementary feeding.
 
Brachydactyly, seen in two patients in our series, is a possible novel feature. Interestingly, tooth enamel
hypoplasia, present in one patient in our series, has previously been reported in another patient with a
ZMYND11 variant (Coe, Witherspoon, Rosenfeld, van Bon, et al., 2014), indicating this may be a rare
and/or overlooked phenotypic feature, although formal dental assessment has not been documented for
most patients.
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In this series, three individuals inherited a predicted pathogenic ZMYND11 variant from their affected
mother; another patient inherited the pathogenic variant from his father on whom detailed phenotypic
information was lacking. Inheritance of a pathogenic ZMYND11 variant from an affected parent has been
previously reported (Coe et al. 2014). Familial inheritance should therefore be considered in variant
filtering and interpretation and reproductive counselling.
 
The majority of patients, including those in our series, have truncating variants, which are likely subject
to nonsense-mediated decay and hence, result in haploinsufficiency (Fig. 2). Of note, the p.(Gln586*)
variant in our series is located in the last exon and therefore may escape nonsense-mediated decay. The p.
(Cys574Arg) variant is similarly located in the last exon. These variants may be expected to have a
deleterious effect through disruption of the MNYD-type zinc finger motif. This motif interacts with a
number of intracellular partners, for example the NCoR transcriptional corepressor (Masselink &
Bernards, 2000), and amino acid variation within this motif has been shown to disrupt binding of these
partners, resulting in reduced efficacy of ZMYND11-mediated transcriptional repression (Kateb et al.,
2013; Masselink & Bernards, 2000). We suspect, therefore, that the two variants affecting the MYND-
type zinc finger motif domain in our series will at least result in a reduced function of the protein. The
phenotype of these patients and a previously reported individual (Coe et al. 2014) with a p.(Gln587del)
variant in this motif is not notably different to those patients harbouring variants causing
haploinsufficiency, supportina loss-of-function mechanism. The p.(Glu416Lys) variant in this series is
not in a functional domain. It has been classified as likely pathogenic given that it is de novo and not
present in the gnomAD database; however further research is required to determine the effect of this
variant.
 
In contrast, two missense pathogenic variants have been reported in patients with notably different
phenotypes to those in this series. The p.(Ser421Asn) variant resulted in a severe Angelman-like
phenotype, and the p.(Arg600Trp) variant caused distinct facial dysmorphism, moderate to severe
intellectual disability, and short stature (Cobben et al., 2014; Moskowitz et al., 2016). Given these distinct
06/03/2020, 08)40
Page 8 of 11https://mc.manuscriptcentral.com/humu?DOWNLOAD=TRUE&PARA…nGQpfCSGRwS4XJVR6D9NHRdvbzUy9AZd84ELx7FRdrFk9tGZpJmTF8x
phenotypes, it is possible that other mechanisms, including a gain-of-function, may be at play, but further
research is required to characterise the effects of these specific variants.
Conclusions
 
We present a series of 16 patients with predicted pathogenic ZMYND11 variants, predicted to result in
haploinsufficiency or reduced protein function, together with a review of the published literature,
allowing further delineation of the associated phenotype. Developmental delay and ID, usually mild to
moderate, are universally present. Behavioural issues are frequent, and hypotonia and seizures are
common. Feeding difficulties occur, but are usually mild. Subtle dysmorphism includes prominent
eyelashes and eyebrows. Novel features include brachydactyly and tooth enamel hypoplasia. Our data
will contribute to successful reverse phenotyping following genomic sequencing.
Data Availability Statement
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Photographs of patients in this series. Patient ages are as follows (y- years; mo – months): 1 – 3y, 2 – 8y,
3 – 5y 10mo, 4 – 8y, 6 – 4y, 7 – 13y 8mo, 9 – 8y, 10 – 2y 7mo, 11 – 15y, 12 – 17y, 13 – 22y, 14 – 20y, 15
– 47y, 16 – 2.5y. Note shared dysmorphic features (particularly in patients 1, 3-14 and 16) including




ZMYND11 protein showing pathogenic variants in this series (below protein) and previously reported
(above protein) (Cobben et al., 2014; Coe, Witherspoon, Rosenfeld, van Bon, et al., 2014; Iossifov et al.,
2012; Moskowitz et al., 2016; Popp et al., 2017) (transcript NM_006624.5, Human Genome Build
GRCh37.p13). Functional domains are labelled according to their location in the protein. The tandem
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Proposed
pathogenic
mechanism Haploinsufficiency: NMD  
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reported 3y 8y 5y 10 mo 8y 8y 4y 13y 8mo 18y 8y 2y 7mo  
Gender F F F M M M M M M F  
Feeding




supplementation) Yes Yes No 5/8 (63%)
Dysmorphic Yes No Yes No Yes No Yes No Yes Yes 6/10(60%)
Delayed




delay 2y 17 mo 2y 2y 2y
Cannot walk










































Yes Yes No Yes No No Yes Yes No No 5/10(50%)
Aggression/
anger No No Yes No Yes No Yes No Yes No 4/10(40%)
Autism/
autistic traits No No Yes No No No No No Yes No
2/10
(20%)
Hypotonia Yes No No Yes No No No Yes Yes No 4/10(40%)
Epilepsy No Yes Yes No No No No No No No 2/10(20%)
 
Proposed pathogenic
mechanism Predicted to disrupt MYND zinc-finger domain Missense Overall Total
Patient no 11 12 13 14 15 Total 16  
DECIPHER ID BWH 264849 GSH 282655       





protein p.(Cys574Arg) p.(Gln586*) p.(Gln586*) p.(Gln586*) p.(Gln586*)  p.(Glu416Lys)  
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Age reported 15y 17y 22y 20y 47y  2y 5 mo  
Gender M M F F F  M  
Feeding problems No No No No nd 0/4 (0%) Yes 5/13 (38%)
Dysmorphic Yes Yes Yes Yes No 4/5 (80%) Yes 11/16 (69%)
Delayed development Yes Yes Yes Yes nd 4/4 (100%) Yes 14/14 (100%)
Gross motor delay 13 mo 2.5 y 18 mo 4y nd 2/4 (50%) Not yet achieved 11/15 (73%)
Speech delay 2-2.5y 4-5y First wordsaround 4y
First words



























special school 5/5 (100%) nd
13/13 (100%)





Yes Yes Yes No No 3/5 (60%) No
8/16 (50%)
Aggression/ anger Yes Yes Yes Yes No 4/5 (80%) No 8/16 (50%)
Autism/ autistic traits Yes No No No No 1/5 (20%) nd
3/15 (20%)
Hypotonia No No No No No 0/5 (0%) Yes 5/16 (31%)




Table 1. Genotypic and phenotypic data for patients in this series, ordered according to likely pathogenic mechanism. Totals include only those patients for whom the
presence or absence of the feature is reported. Mutation nomenclature according to Human Genome Variation Society (HGVS) recommendations
(http://varnomen.hgvs.org/). All variants were analysed according to transcript NM_006624.5. American College of Medical Genetics and Genomics sequence
interpretation criteria according to Richards et al., 2015.
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Proposed
pathogenic
mechanism Haploinsufficiency:NMD        
Disruption of
MYND zinc-
finger domain  















































Splice variant Frameshift Frameshift Frameshift Nonsense Frameshift Frameshift Frameshift In-frame  
Feeding
problems nd nd nd nd nd nd Yes nd Yes 2/2 (100%)
Dysmorphic nd Yes No Yes Yes Yes nd Yes Yes 6/7 (86%)
Gross motor
delay nd nd Yes Yes nd Yes nd nd nd 3/3 (100%)
Speech delay nd Nonverbal Yes Yes Yes Yes nd nd Yes 6/6 (100%)
ID nd Severe nd Mild Mild Mild Severe Yes Mild 7/7 (100%)
Behavioural





nd nd nd No No Yes nd No nd 1/4 (25%)
Aggression/
anger nd nd nd No nd Yes Yes No nd 2/4 (50%)
Autism/
autistic traits Yes Yes nd Yes nd No nd No No 3/6 (50%)
Neurological
abnormality nd Yes Yes No nd No Yes nd Yes 4/6 (67%)
Hypotonia nd Yes No Yes nd nd Yes nd Yes 4/5 (80%)
Epilepsy nd Yes Yes No nd No Yes nd No 3/6 (50%)
 
Table 2. Genotypic and phenotypic data for all previously reported patients with ZMYND11 variants, ordered according to likely pathogenic mechanism, with summary
total including this series. Totals include only those patients for whom the presece or absence of the feature is reported. Mutation nomenclature according to Human
Genome Variation Society (HGVS) recommendations (http://varnomen.hgvs.org/). All variants were analysed according to transcript NM_006624.5. American College of
Medical Genetics and Genomics sequence interpretation criteria according to Richards et al., 2015.
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Figure 1: Photographs of patients in this series. Patient ages are as follows (y- years; mo – months): 1 – 3y, 2 – 8y, 3 –
5y 10mo, 4 – 8y, 6 – 4y, 7 – 13y 8mo, 9 – 8y, 10 – 2y 7mo, 11 – 15y, 12 – 17y, 13 – 22y, 14 – 20y, 15 – 47y, 16 – 2.5y.
Note shared dysmorphic features (particularly in patients 1, 3-14 and 16) including prominent eyelashes and flattened
nasal bridge with bulbous nasal tip. 
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Figure 2: ZMYND11 protein showing pathogenic variants in this series (below protein) and previously reported (above
protein) (Cobben et al., 2014; Coe, Witherspoon, Rosenfeld, van Bon, et al., 2014; Iossifov et al., 2012; Moskowitz et al.,
2016; Popp et al., 2017) (transcript NM_006624.5, Human Genome Build GRCh37.p13). Functional domains are labelled
according to their location in the protein. The tandem PWWP (Pro-Trp-Trp-Pro)-Bromo domains function in recognising
H3K36 trimethylation. 
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Patient 1
 
This 3-year-old female is the only child of non-consanguineous Caucasian parents. There is no family history of
developmental delay.
 
She was born at 37 weeks’ gestation following a pregnancy complicated by hyperemesis gravidarum,
subchorionic hemorrhage, and nuchal cord x 2. Birth weight was 2400 g. She was born with congenital bilateral
hip dysplasia, which resolved with a Pavlik harness. She was noted to have hypotonia since birth and had
difficulty with feeding during the first three months of life, requiring high-caloric formula supplementation in
addition to breastfeeding.
 
She was evaluated by Early Intervention services at 6 months of age due to global developmental delay and
qualified for speech and physical therapy. She sat independently at age 8-9 months, which coincided with the
time her leg braces were removed, walked independently at age 2 years, and climbed stairs assisted by a railing
at age 3 years. Age at first words is unknown; however, she spoke ~24 words with some 2-word phrases at 2
years, though speech remains mostly unintelligible to strangers at age 3 years. Receptive language is better than
expressive language.
 
Socially, she is an interactive and happy child. She has exhibited significant interest in objects, but there is no
concern for restricted interests. She does exhibit biting and hitting behavior when frustrated and occasional
hand-flapping behavior when in unfamiliar situations; however, there is no overall concern for a behavioral
disorder.
 
Physical exam at age 3 years and 2 months showed a height of 93.4 cm (-0.49 SD), weight of 13.9 kg (-0.21
SD), and occipitofrontal head circumference (OFC) of 48.3 cm (25th percentile). She had generalized hypotonia
and bilateral fifth finger clinodactyly. Facial dysmorphisms included micrognathia, widow’s peak, mild
hypertelorism, small earlobes, broad single uvula, high palate, and thin vermilion of upper lip.
 
Previous investigations included normal 46,XX karyotype and negative chromosome 15q methylation studies.





This 8-year old child is the daughter of non-consanguineous parents. Neither the parents nor siblings exhibit a
phenotype similar to the patient’s.
 
She was born at 42 weeks’ gestation following an uncomplicated pregnancy. Birth weight was 3.1 kg. There
were no neonatal complications and no feeding difficulties.
 
Developmental milestones were globally delayed. At the age of 7.5 years, she had mild intellectual disability
(ID) and was two to three years behind her expected levels in some subjects. She attended a mainstream school
with additional learning support. 
 
She displayed impulsive behavior, attention difficulties, hyperactivity and had significant mood swings. She also
had episodes of shaking her head side-to-side occurring usually in bright sunlight, which were thought to be
non-epileptic in nature.
 
She had epilepsy with seizures involving vacant staring episodes and rolling of the eyes upward. Focal and
generalized abnormalities were noted on EEG. Cranial MRI scan was normal.
 
Physical exam at age five years demonstrated OFC 51.5 cm. She did not show any facial dysmorphisms.
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Patient 3
 
This 5 years and 10 month old female was born at term after an uncomplicated pregnancy. Birth weight was
3.25kg. There were no neonatal complications. Neither the parents nor siblings exhibit a phenotype similar to
the patient’s.
 
Developmental milestones have been delayed, with the patient sitting at 12 months and walking at 24 months.
Language development was delayed and she had three word sentences at four years age. She had temper
tantrums and was also diagnosed as having an autism spectrum disorder. She had epilepsy, and frontotemporal
spikes were seen on EEG.  
 
Physical exam at age 4 years 7 months demonstrated height 107cm, weight 17.35kg and OFC 51cm. Facial
dysmorphisms include scaphocephaly, prominent forehead, synophrys, upslanting palpebral fissures, broad nasal
bridge, bubous nasal tip, mild epicanthal folds, flat philtrum and small chin. She also had 5th finger clinodactyly
and short fingers.
 




This 8-year old child is the son of non-consanguineous parents. The parents do not have a similar phenotype as
the patient.
 
He was born at 36 weeks via induced delivery due to reduced fetal movements. Birth weight was 1.98 kg. The
delivery was complicated by perinatal asphyxia, and he had apnoeic episodes over the first 24 hours. He was
admitted to Neonatal Intensive care and required nasogastric feeding.
 
Developmental milestones have been delayed. Social smile was at 11 weeks age and sitting independently was
achieved at 12 months. Walking independently and first words were achieved at two years of age.
 
At the age of eight years, he had mild intellectual disability. He had a short attention span, and anxiety. He had
an ataxic gait and myoclonic jerks affecting the face, shoulders, arms, and hands. He was also noted to have
axial hypotonia, a dystonic posture of the feet during walking, excess drooling and slurred speech. Cranial MRI
demonstrated perirolandic atrophy, a small area of increased signal in the right thalamus, small thalami, and
secondary hypomyelination due to cortical damage in both internal capsules, affecting the left more than right.
His phenotype was not thought to be explained by perinatal asphyxia.
 
Physical exam at age seven years demonstrated height 123.9 cm, weight 24.6 kg, and OFC 52 cm. He was not




This 8-year-old child is the son of non-consanguineous parents. Neither the parents nor siblings exhibit a
phenotype similar to the patient’s.
 
He was born at 38+4 weeks’ gestation following a pregnancy complicated by maternal cholecystitis treated by
cholecystectomy. Prenatal ultrasound demonstrated a hyperechogenic structure in the right wall of the ventricle.
Birth weight was 2.9 kg. There were no neonatal complications, and cardiac ultrasound after birth was normal.
 
Developmental milestones have been delayed, with the patient sitting independently late, walking independently
at 2 years, and having first words at 3 years. He developed 2-word phrases at 3 years and 6 months.
Additionally, socio-emotional development is significantly delayed, and he exhibits aggressive behavior. Socio-
emotional developmental age of 2 years at calendar age of 8 years. TIQ is 84.
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Additionally, the patient has had progressive obesity since childhood. He also exhibited sudden-onset double
vision at 7 years with no other neurological abnormalities and normal cranial MRI. At that time, he was already
known to have anisometropy and hypermetropy.
 
Physical exam at age 6 years demonstrated height at 0 SD and weight at +3 SD, with OFC at +1.7 SD at age 7
years and10 months. Facial dysmorphisms include round face with periorbital fullness and esotropia, low and
broad nasal bridge with epicanthal folds, and full nasal tip. He also has mild brachydactyly of the hands and feet,
mild hypermobility, and toe nails that break easily and fragile enamel of teeth.
 
Previous investigations included testing for a panel of 500 genes associated with intellectual disability (ID)
(ZMYND11 not yet included). Chromosomal microarray showed a mat7q36.1 dup (including the KMT2C and




This 4-year old child is the son of non-consanguineous parents. Neither the parents nor siblings exhibit a
phenotype similar to the patient’s.
 
He was born at 40 weeks’ gestation after an uncomplicated pregnancy. Birth weight was 2.98kg. There were no
neonatal complications and no feeding difficulties.
 
Developmental milestones have been delayed, with social smile at 14 weeks of age and sitting independently at
16 months of age. Walking independently and speech were not yet achieved at the age of four years.
 
He had two generalized non-febrile seizures at the age of four years. Cranial MRI demonstrated bilateral
frontoparietal polymicrogyria.
 
Physical exam at age two years demonstrated length 80cm, weight 9.6kg, and OFC 45cm. He was not thought to
have dysmorphic features.
 




This 13 years and 8 month old child is the son of non-consanguineous parents. His mother was thought to have
some shared phenotypic features, although it is not known if she carries the same ZMYND11 variant.
 
He was born at 42 weeks’ gestation, and there was thought to be maternal alcohol and recreational drug use
during pregnancy. Birth weight was 3.54kg. He was discharged from hospital soon after birth but required
readmission at one month of age due to excessive vomiting after feeding. He needed gastrostomy feeding at that
time.
 
Developmental milestones have been delayed, with the patient sitting independently at 10 months of age,
walking independently at 22 months age, and developing first words at 2 years of age, although these were
difficult to understand until 3 years
 
Physical exam at age 13 years and 8 months demonstrated height 155.6cm, weight 46.5kg and OFC 53.5cm.
Facial dysmorphisms included round face, hypertelorism, thin top lip, underdeveloped nasal alae, clinodactyly
of the 5th finger and down-sloping shoulders. At 3 years of age he had a prominent metopic ridge, which
became less prominent over time. He had challenging hyperactive, aggressive and impulsive behavior, and he
was diagnosed with attention deficit hyperactivity disorder at 11 years.
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This 18-year-old male was born to non-consanguineous parents. Neither parents nor siblings had a similar
phenotype; a maternal cousin was reported to have autistic features and developmental delay.
 
He was born at 39 weeks’ gestation, after a pregnancy complicated by placental abruption. Birth weight was
3.38kg. There was no requirement for Special Care, although he was noted to have feeding difficulties.
Developmental milestones have been delayed, with the patient walking independently at 18 months and
achieving first words at four years of age.
 
The patient developed a hyperactivity disorder, as well as spinal kyphosis and axial hypotonia. Cranial MRI was
normal, and EEG showed background disorganization with no epileptic activity. Physical exam at age 18 years
demonstrated height 178cm, weight 73kg and OFC 57.5cm. He had a supernumerary nipple, and was not
thought to be dysmorphic.
 




This 8-year old child is the son of non-consanguineous parents. His father had macrocephaly.
 
He was born at 42 weeks’ gestation after an uncomplicated pregnancy. Birth weight was 4.76kg.  There were
some early feeding difficulties.
 
Developmental milestones have been delayed, with the patient sitting independently at 13 months. Independent
walking and first words were achieved at 2.5 years of age.
 
At eight years of age, he had mild ID and was dyspraxic. He attended a mainstream school with extra help. He
had episodes of aggressive behaviour, which could be difficult to manage. He had autistic traits but did not meet
the criteria for a formal diagnosis of autism spectrum disorder. Cranial MRI scan demonstrated
ventriculomegaly.
 
Physical exam at age three years demonstrated height 104.8 cm, weight 18.9kg and OFC 55.5cm. Facial
dysmorphisms included epicanthus, long eyelashes, heterochromia and macrocephaly. There was a single black
macule on the scalp. The patient also had pectus excavatum, clinodactyly of the 5th finger, pes planus, hypotonia
and joint hypermobility.
 




This two year seven month old child was noted to be small for gestational age on prenatal scans. She was born at
39+6 weeks gestation with a birth weight of 2.35kg (<0.4th centile). She did not require Special Care and did not
have any feeding problems.
 
Developmental milestones have been delayed. Social smile was at eight to nine weeks, sitting independently at
11 months and she was cruising at two years of age. At two-and-a-half years age she was not walking
confidently on her feet, although she did walk on her knees. After two years of age, she could say ‘up’ and ‘no’.
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She was thought to be a generally placid child, but could get frustrated when not understood. She can express
her wants with gestures or vocalisations, to some degree.
 
Physical exam at two years and seven months of age demonstrated height on the 2nd centile, weight 4th centile
and OFC 1st centile. She had narrow palpebral fissures, retrognathia, hypoplastic toenails, marked joint
hypermobility, especially distally, and a hirsute back.
 




This 15 year old child is the son of non-consanguineous parents. Neither the parents nor siblings exhibit a
phenotype similar to the patient’s.
 
He was born at 40 weeks’ gestation following an uncomplicated pregnancy. There were no neonatal
complications, and no feeding difficulties.
 
Developmental milestones have been delayed, especially speech. Independent walking was achieved at 13
months, and his first words were at 2.5 years.
 
At the age of 15 years, he had moderate ID and attended a special school. He had autistic spectrum disorder and
attention deficit hyperactivity disorder, and he displayed some aggressive behaviours. He was prescribed
risperidone and methylphenidate.
 
He had epilepsy with generalized and absence seizures as a child, although this has resolved and he no longer
requires anti-epileptic medication. He also had discoloured teeth with poor enamel formation, and required four
extractions for dental caries. He also had bilateral strabismus.
 
Physical exam at age 15 years demonstrated height 164.3cm, weight 74.8kg and OFC 58cm. Facial
dysmorphism included prominent eyebrows, deep-set eyes, hypoplastic alae nasi and wide mouth. He also had
pes planus, achilles tendon contracture and hypoplastic nails.
 




This 17 year old is the son of non-consanguineous parents. His mother and two sisters were thought to have a
similar phenotype. He was born at 42 weeks’ gestation after an uncomplicated pregnancy. Birth weight was
3.2kg. He required five days in Special Care.
 
Developmental milestones have been delayed, with the patient walking independently at 2.5 years age. His first
words were between 4-5 years. He had ID, with special educational needs. He was in simple employment
following school. He had attentional difficulties, and displayed some aggressive/angry behaviours.
 




This 22 year old female is the sister of patient 7. She was born at 34 weeks’ gestation after an uncomplicated
pregnancy. Birth weight was 3.28kg. There were no neonatal complications.
 
Developmental milestones have been delayed, with the patient walking independently at 18 months and
developing first words at approximately four years of age. She had ID with special educational needs and was
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attending college after school. She had attentional difficulties and displayed some aggressive/angry behaviours.
 





This 20 year old female is the sister of patients 7 & 8. She was born at term after an uncomplicated pregnancy.
Birth weight was 3.03kg. There were no neonatal complications.
 
Developmental milestones have been delayed, with the patient walking independently at four years of age. Her
first words were at approximately four years of age. She had ID with special educational needs. She was
working in retail after school. She had some aggressive/angry behaviours.
 





This 47 year old female is the mother of patients 7-9. She had special educational needs and had epilepsy as a




This 2-year-old male is the child of non-consanguineous parents. Neither the parents nor siblings exhibit a
phenotype similar to the patient’s.
 
He was born at 39+2 weeks’ gestation following an uncomplicated pregnancy. Prenatal scans demonstrated
accelerated growth, but no other abnormalities were detected. Birth weight was 4735 g. He had feeding
difficulties early in life, with bottle feeding taking > 1 hour.
 
His development has been delayed, with social smile developing at 8 weeks, independent sitting at 16 months,
and walking not yet achieved by age 29 months. Speech is also absent at 29 months. Evaluation by Bayley-III-
NL showed a developmental age of 11 months at calendar age of 26 months. Behaviorally, he exhibits
automatisms, mouthing, body rocking, drooling, breath holding spells, and outbursts of screaming. He does not
make eye contact.
 
This patient also has significant neurological abnormalities, including benign external hydrocephalus. Initially,
he exhibited hypertonia and hyperreflexia of the extremities and later developed mild axial hypotonia. He has
dystonic movements of the hands and choreatic movements of the arms. Cardiac evaluation showed no
structural abnormalities.
 
Physical exam at age 2 years and 5 months showed a height of 95 cm, weight of 15 kg, and OFC of 52 cm.
Dysmorphic facial features include plagiocephaly, broad forehead, small eyes, downturned corners of mouth,
uplifted right earlobe, and chin dimple. Physical exam also demonstrates strabismus convergens, rotary
nystagmus, a sacral dimple, and pedes planovalgus.
 
Previous investigations included Sanger sequencing of L1CAM, FMR1 repeat length analysis, and chromosomal
microarray, none of which revealed any abnormalities.
 
